Literature DB >> 18835660

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.

Michael Kluge1, Andreas Schuld, Alexander Schacht, Hubertus Himmerich, Mira A Dalal, Peter M Wehmeier, Dunja Hinze-Selch, Thomas Kraus, Ralf W Dittmann, Thomas Pollmächer.   

Abstract

The second generation antipsychotics clozapine and olanzapine are known to cause weight gain. However, only clozapine is associated with drug-induced fever. Cytokines have been linked to the induction of both weight gain and drug-induced fever. We investigated these potential side effects of clozapine and olanzapine and studied their differential effects on cytokine secretion. Thirty patients suffering from schizophrenia, schizophreniform disorder or schizoaffective disorder were treated with either clozapine (mean modal dose: 266.7+/-77.9mg) or olanzapine (21.2+/-2.5mg) in a randomized, double-blind, 6-week study. Body mass index (BMI), tympanic temperature, and plasma levels of leptin and cytokines (tumor necrosis factor-alpha (TNF-alpha), soluble TNF receptor 1 and 2 (sTNFR-1/2), soluble interleukin-2 receptors (sIL-2R), interleukin-6) were determined weekly. BMI, leptin and cytokines significantly increased over time, except interleukin-6 and sTNFR-1 in the olanzapine group. All cytokines numerically increased compared to baseline already during the first week of treatment in both groups. Leptin, TNF-alpha, sTNFR-1, sTNFR-2 and sIL-2R levels correlated with the BMI. Five patients who received clozapine (33%) developed drug-induced fever (>/=38 degrees C). In these, interleukin-6 peak levels were significantly (p<0.01) higher than in those patients treated with clozapine who did not develop fever. In conclusion, increase of BMI appears to be related to clozapine's and olanzapine's similar effects on cytokine systems, whilst drug-induced fever appears to be related to clozapine's differential effects on interleukin-6.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835660     DOI: 10.1016/j.psyneuen.2008.08.016

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  32 in total

1.  Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin.

Authors:  Theodoros Kelesidis; Iosif Kelesidis
Journal:  Clin Ther       Date:  2009-12       Impact factor: 3.393

2.  Management of clozapine-induced fever in a child.

Authors:  David I Driver; Afsoon A Anvari; Christina M Peroutka; Rachna Kataria; Jerry Overman; David Lang; Maria Tietcheu; Reggie Parker; Keith Baptiste; Judith L Rapoport; Nitin Gogtay
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

3.  Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.

Authors:  K van der Weide; H Loovers; K Pondman; J Bogers; T van der Straaten; E Langemeijer; D Cohen; J Commandeur; J van der Weide
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

4.  In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study.

Authors:  S E Holmes; R Hinz; R J Drake; C J Gregory; S Conen; J C Matthews; J M Anton-Rodriguez; A Gerhard; P S Talbot
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

Review 5.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

6.  Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report.

Authors:  Charilaos Gerasimou; Georgia Phaedra Vitali; George D Vavougios; Charalabos Papageorgiou; Athanasios Douzenis; Styliani I Kokoris; Ioannis Liappas; Emmanouil Rizos
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

7.  Effect of clozapine on immunoglobulin M plasma levels.

Authors:  Roberto Lozano; Reyes Marin; Maria-Jesus Santacruz; Asunción Pascual
Journal:  Ther Adv Psychopharmacol       Date:  2016-02

8.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 9.  Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications.

Authors:  Trehani M Fonseka; Daniel J Müller; Sidney H Kennedy
Journal:  Mol Neuropsychiatry       Date:  2016-01-08

Review 10.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.